AFT Pharmaceuticals (ASX: AFP) has reached an agreement with Alexso to distribute Combogesic (Maxigesic Rapid Tablets) in the United States, the largest pharma market in the world.
“We are delighted to announce our partnership with Alexso, an established pharmaceutical distribution company which prioritises non-opioid pain management solutions,” AFT Pharmaceuticals Managing Director Dr Hartley Atkinson said.
“We are pleased to be launching our second patented pharmaceutical into the United States market, which we anticipate will occur during this financial year.”
Troy Farahmand, President of Alexso, said the company is thrilled to introduce Combogesic to our portfolio of non-opioid pain management solutions.
“This partnership with AFT Pharmaceuticals aligns perfectly with our commitment to offering physicians effective alternatives to opioids. Combogesic will play a crucial role in our mission to combat pain while reducing the reliance on addictive opioid medications.”
AFT’s negotiations continue to progress with other distributors for additional specific market channels in the United States.
